Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study: Induction Chemotherapy Followed by Transoral Robotic Surgery and Neck Dissection for Definitive Management of Oropharyngeal Squamous Cell Carcinoma. (NECTORS Trial)

NCT04277858 is registered in ClinicalTrials.gov with Nader Sadeghi as lead sponsor.

NCT NCT04277858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04277858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study: Induction Chemotherapy Followed by Transoral Robotic Surgery and Neck Dissection for Definitive Management of Oropharyngeal Squamous Cell Carcinoma. (NECTORS Trial)
Lead sponsor
Nader Sadeghi
Phase
Phase 2
Overall status
Recruiting
Start date
August 14, 2018
Completion date
August 30, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

base of the tongue carcinoma, oropharynx cancer, throat cancer, tonsil cancer